Computer-assisted Curie scoring for metaiodobenzylguanidine (mIBG) scans in patients with neuroblastoma

MLA

Roger Engelmann, et al. “Computer-Assisted Curie Scoring for Metaiodobenzylguanidine (MIBG) Scans in Patients with Neuroblastoma.” Journal of Clinical Oncology, vol. 34, May 2016, p. 10559. EBSCOhost, https://doi.org/10.1200/jco.2016.34.15_suppl.10559.

APA

Roger Engelmann, Samuel L. Volchenboum, Daniel Appelbaum, Susan L. Cohn, Helen Nadel, Barry L. Shulkin, Wenjun Kang, Hollie Lai, Navin Pinto, Elizabeth A. Sokol, Adam Starkey, Gregory A. Yanik, Samuel G. Armato, & Yonglin Pu. (2016). Computer-assisted Curie scoring for metaiodobenzylguanidine (mIBG) scans in patients with neuroblastoma. Journal of Clinical Oncology, 34, 10559. https://doi.org/10.1200/jco.2016.34.15_suppl.10559

Chicago

Roger Engelmann, Samuel L. Volchenboum, Daniel Appelbaum, Susan L. Cohn, Helen Nadel, Barry L. Shulkin, Wenjun Kang, et al. 2016. “Computer-Assisted Curie Scoring for Metaiodobenzylguanidine (MIBG) Scans in Patients with Neuroblastoma.” Journal of Clinical Oncology 34 (May): 10559. doi:10.1200/jco.2016.34.15_suppl.10559.